
Nippon India Pharma Fund - IDCW Option - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of September 30, 2025
Asset Allocation
Equity: 99.47%Others: 0.53%
Market Cap
Large Cap: 33.27%Mid Cap: 33.86%Small Cap: 31.35%Equity: 0.99%
Number of stocks
37
Top 10 Holdings
116.11% of portfolio
Market Cap of Equity
Large Cap
33.2701%
Mid Cap
33.8594%
Small Cap
31.3509%
Equity
0.9931%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd24.59%
Lupin Ltd14.53%
Divi's Laboratories Ltd14.03%
Cipla Ltd12.95%
Apollo Hospitals Enterprise Ltd11.85%
Dr Reddy's Laboratories Ltd11.81%
Vijaya Diagnostic Centre Ltd7.12%
Medplus Health Services Ltd6.77%
Gland Pharma Ltd6.48%
GlaxoSmithKline Pharmaceuticals Ltd5.99%
Sector Allocation of Equity
Healthcare99.47%
SIP Amount
₹
Monthly SIP Date
Nippon India Pharma Fund - IDCW Option


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started. 
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.